Venrock partner Nimish Shah speaks with Jason Fenton, managing director and head of health care capital markets at Cowen, to discuss the explosion of activity in the biotech IPO market this year. Fenton dives into the pros and cons of a virtual IPO process and shares best practices for companies looking to go public. Shah and Fenton outline some of the important factors to consider when choosing a bank and touch on common mistakes CEOs make while going through an IPO. Fenton also walks through the components of a recent successful IPO deal and provides his expectations for the biotech market in 2021. 

  • Subscribe:


Want more? Here’s the latest on Running Through Walls.

Not knowing where items are located, what’s in stock, or if they are properly priced cost the global retail industry more than a trillion dollars. Venrock partner David Pakman speaks with Brad Bogolea, co-founder and CEO of Simbe Robotics, about how Simbe’s robot Tally is solving these major blind spots. Bogolea delves into how robotic solutions can keep up with rapid changes without overhauling infrastructure and provide greater optical data than traditional solutions. Bogolea discusses the competitive and consumer pressures prompting retailers to embrace robotic solutions and how the pandemic exposed the need for autonomy and better data. Bogolea also touches on the challenges of financing in the robotics sector, and how being customer-oriented is key to Simbe’s success. 
  1. Automating Inventory Management
  2. Biotech's Digital Transformation
  3. What Financial Advice Should Be
  4. The Recipe for Drug Discovery
  5. No Egos, No Jerks, No Politics